Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liansong Yiboting Tablets in Coronary Heart Disease with Ventricular Premature Beats
CTR20201327Phase 2Active
- Sponsor
- Jiangxi Baishen Pharmaceutical
- Start
- Jul 2020
- Countries
- 1
01
Overview
A Phase 2 trial of Liansong Yiboting Tablets in coronary arteriosclerosis, Premature ventricular complexes (PVC), sponsored by Jiangxi Baishen Pharmaceutical. Started Jul 2020; status: active.
02
Drugs
Liansong Yiboting Tablets
03
Conditions
coronary arteriosclerosisPremature ventricular complexes (PVC)
Beyond the preview
Go deeper on CTR20201327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201327.